Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Subjects:

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

Immunohistochemical analysis of p-Akt expression in various experimental groups showing negative expression in control group, marked increased expression along the extended fibrous bands (upper insert) in TAA group, significant dose-related decreased expression following the decreased fibroplasia in RBO treated groups, and limited expression in SIL treated group. by Rehab F. Abdel-Rahman (11886404)

Effect of compound 16 on cell cycle progression in HCT-116 cells after 48h treatment. by Ahmed A. Gaber (13302308)

Subjects:

The effect of increasing/decreasing confederates’ confidence on participants’ responses. by Winny W. Y. Yue (11146428)

Effect of compound 16 on stages of the cell death process in HCT-116 cells after 48 h treatment. by Ahmed A. Gaber (13302308)

Subjects:

The fasting-refeeding regimen increased Akt phosphorylation. by Tucker Hopkins (20790529)

Subjects:

Effect of compound 16 on the levels of BAX, and Bcl-2 proteins expression in HCT-116 cells treated for48 h. by Ahmed A. Gaber (13302308)

Subjects:

Effect of compound 16 and m-AMSA on relaxation of supercoiled pBS-SK (+) DNA by human recombinant Topo II. by Ahmed A. Gaber (13302308)

Subjects:

Pixel-wise trends in annual time series data of NDVI and Tmin during 1982 to 2015 (a) Sen’s slope of NDVI (b) p-values of NDVI, (c)significant trends (p<0.05) in average annual slo... by Jamal Hassan Ougahi (13513875)

Subjects:

3D interactions between the ligand and the protein_DNA complex in the first (C1) and second (C2) clusters. by Ahmed A. Gaber (13302308)

Subjects:

Binding of compound 16 with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

Binding of amsacrine with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

The center of mass distances between the protein-DNA complex and the ligand (Blue line), and the protein and DNA (red line). by Ahmed A. Gaber (13302308)

Subjects:

Fig 12 - by Ahmed A. Gaber (13302308)

Subjects:

General procedure for the synthesis of the target compounds 11a,b,15a,b. by Ahmed A. Gaber (13302308)

Subjects:

Binding of compound 11a with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

General procedure for the synthesis of the target compounds 16–20. by Ahmed A. Gaber (13302308)

Subjects:

The number of clusters, number of interactions, and their types between the ligand and protein_DNA complex. by Ahmed A. Gaber (13302308)

Subjects: